Source: Annual Congress 2004 - Pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Garcia, A. Brandao (Porto Alegre, Brazil). Sildenafil for patients with portopulmonary hypertension, candidates to hepatic transplant. Eur Respir J 2004; 24: Suppl. 48, 766

Member's Comments

No comment yet.

Related content which might interest you: Intravenous iloprost bridging to orthotopic liver transplantation in portopulmonary hypertension Source: Eur Respir J 2004; 24 : 703-707 Year: 2004 Association between portopulmonary hypertension and hepatopulmonary syndrome in cirrhotics, candidates to hepatic transplantation Source: Annual Congress 2003 - Pulmonary hypertension Year: 2003 Resolution of portopulmonary hypertension (POPH) following liver transplantation Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH Year: 2012 Sildenafil treatment for portopulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 651s Year: 2006 Experience with inhaled iloprost and bosentan in portopulmonary hypertension Source: Eur Respir J 2007; 30: 1096-1102 Year: 2007 Sildenafil treatment for portopulmonary hypertension Source: Eur Respir J 2006; 28: 563-567 Year: 2006 Portopulmonary hypertension and hepatopulmonary syndrome: a clinician-oriented overview Source: Eur Respir Rev 2012 21:223-233 Year: 2012 The prevalence of pulmonary hypertension in cirrhotic patients submitted to hepatic transplantation Source: Eur Respir J 2003; 22: Suppl. 45, 465s Year: 2003 Iloprost treatment in portopulmonary hypertension Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008 Long-term outcome of patients with portopulmonary hypertension treated with sildenafil Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009 Portopulmonary hypertension Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=129 Year: 2005 Outcome of candidates for liver transplantation suffering from portopulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Liver transplantation in hepatopulmonary syndrome and portopulmonary hypertension Source: Annual Congress 2003 - Pulmonary-hepatic disorders (PHD) - recommendations of the PHD ERS Task Force for management of hepatopulmonary syndrome and portopulmonary hypertension Year: 2003 Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension Source: Eur Respir J 2009; 34: 770 Year: 2009 Efficacy, safety and pharmacokinetics of bosentan in portopulmonary hypertension Source: Eur Respir J 2013; 41: 96-103 Year: 2013 The prevalence of hepatopulmonary syndrome in 445 patients, candidates to hepatic transplant Source: Eur Respir J 2004; 24: Suppl. 48, 562s Year: 2004 The lung in liver disease: hepatopulmonary syndrome and portopulmonary hypertension Source: Eur Respir Monogr 2019; 86: 262-277 Year: 2019 Portopulmonary hypertension: a consequence of portal hypertension Source: Eur Respir Mon 2012; 57: 58-70 Year: 2012 An autopsy case of portopulmonary hypertension associated with idiopathic portal hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Inhaled iloprost for patients with portopulmonary hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 462s Year: 2003